Title       : Plasma Modified Surfaces for Enhanced Endothelialization for Improved Biomedical
               Implants
Type        : Award
NSF Org     : DMI 
Latest
Amendment
Date        : December 24,  1992  
File        : a9260601

Award Number: 9260601
Award Instr.: Standard Grant                               
Prgm Manager: Kesh S. Narayanan                       
	      DMI  DIV OF DESIGN,MANUFAC & INDUSTRIAL INNOV
	      ENG  DIRECTORATE FOR ENGINEERING             
Start Date  : January 1,  1993    
Expires     : September 30,  1993  (Estimated)
Expected
Total Amt.  : $50000              (Estimated)
Investigator: Ih-Houng Loh   (Principal Investigator current)
Sponsor     : Adv Surface Technol Inc
	      9 Linnell Circle
	      Billerica, MA  018213902    508/663-7652

NSF Program : 5371      SMALL BUSINESS PHASE I
Fld Applictn: 0203000   Health                                  
              59        Engineering NEC                         
Program Ref : 5345,
Abstract    :
              The goal of this research project is                                           
              to create a biomaterial substrate to                                           
              support endothelial-specific                                                   
              adhesion and proliferation to                                                  
              further impart thromboresistance to                                            
              bioimplants.  Exposure of blood to                                             
              an artificial surface usually leads                                            
              to the activation of the intrinsic                                             
              pathway of the plasma coagulation                                              
              cascade and to the activation of                                               
              platelets which are often                                                      
              accompanied by the formation of a                                              
              thrombus or blood clot.  A popular                                             
              technique for imparting                                                        
              thromboresistance to biomaterials                                              
              has involved the endothelialization                                            
              ("endothelial seeding") of                                                     
              biomaterial surfaces.  Successful                                              
              endothelialization of biomedical                                               
              implants may improve                                                           
              biocompatibility and aid in reducing                                           
              antigenicity and thromboginicity of                                            
              vascular grafts.                                                               
                                                                                             
              The techniques of producing                                                    
              precultured endothelialized surfaces                                           
              and seeding material with blood                                                
              containing endothelial cells may                                               
              require a specialized biomaterial                                              
              surface to support cell adhesion.                                              
              This research will use plasma                                                  
              surface modification technology to                                             
              incorporate hydroxyl functional                                                
              groups onto the polymeric bioimplant                                           
              surface.  The cell-binding peptides                                            
              will be immobilized to the                                                     
              previously modified bioimplant                                                 
              surface with tresyl chloride                                                   
              chemistry.
